Expert Interview
A look at Axsome's AXS-12 (reboxetine) and the data from Phase 3 ENCORE trial in patients with narcolepsy with cataplexy.
Ticker(s): AXSMInstitution: University of Michigan
- Assistant Professor in the Department of Neurology and the Director of the Collegiate Sleep Disorders Clinic.
- Currently manages 100 patients with Narcolepsy.
- Chair or co-chair in several key national committees including American Academy of Sleep Medicine (AASM) Education Committee member, Chair of Educational Subcommittee: Sleep Health Website, Educational Subcommittee Co-chair, Sleep and Anesthesia Narcolepsy Task Force.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
